Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonist. [electronic resource]
- The Journal of pharmacology and experimental therapeutics Feb 1994
- 747-52 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't